- Home
- BHRB vs XNCR Comparison
BHRB vs XNCR Comparison
Compare BHRB & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHRB | XNCR |
|---|---|---|
| Founded | 1852 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.8M | 881.9M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BHRB | XNCR |
|---|---|---|
| Price | $64.56 | $11.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $71.80 | $22.33 |
| AVG Volume (30 Days) | 134.3K | ★ 617.5K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | ★ 173.76 | 65.36 |
| EPS | ★ 1.79 | N/A |
| Revenue | N/A | ★ $125,576,000.00 |
| Revenue This Year | $36.62 | N/A |
| Revenue Next Year | $10.06 | $4.80 |
| P/E Ratio | $35.54 | ★ N/A |
| Revenue Growth | N/A | ★ 13.65 |
| 52 Week Low | $55.43 | $6.92 |
| 52 Week High | $70.90 | $18.69 |
Technical Indicators
Market Signals| Indicator | BHRB | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 57.12 | 47.67 |
| Support Level | $61.14 | $10.83 |
| Resistance Level | $67.47 | $12.65 |
| Average True Range (ATR) | 1.36 | 0.53 |
| MACD | 0.18 | 0.04 |
| Stochastic Oscillator | 78.23 | 68.29 |
Price Performance
Historical ComparisonAbout BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.